These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 23466411)

  • 1. The risks of post-operative complications following pre-operative infliximab therapy for Crohn's disease in patients undergoing abdominal surgery: a systematic review and meta-analysis.
    Rosenfeld G; Qian H; Bressler B
    J Crohns Colitis; 2013 Dec; 7(11):868-77. PubMed ID: 23466411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy.
    Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ
    Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative infliximab use and postoperative complications in Crohn's disease: a systematic review and meta-analysis.
    Yang ZP; Hong L; Wu Q; Wu KC; Fan DM
    Int J Surg; 2014; 12(3):224-30. PubMed ID: 24394691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor necrosis factor and postoperative complications in Crohn's disease: systematic review and meta-analysis.
    Kopylov U; Ben-Horin S; Zmora O; Eliakim R; Katz LH
    Inflamm Bowel Dis; 2012 Dec; 18(12):2404-13. PubMed ID: 22467533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients.
    Appau KA; Fazio VW; Shen B; Church JM; Lashner B; Remzi F; Brzezinski A; Strong SA; Hammel J; Kiran RP
    J Gastrointest Surg; 2008 Oct; 12(10):1738-44. PubMed ID: 18709420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative infliximab is not associated with an increase in adverse events in Crohn's disease.
    Regueiro M; El-Hachem S; Kip KE; Schraut W; Baidoo L; Watson A; Swoger J; Schwartz M; Barrie A; Pesci M; Binion D
    Dig Dis Sci; 2011 Dec; 56(12):3610-5. PubMed ID: 21681507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry.
    Lichtenstein GR; Feagan BG; Cohen RD; Salzberg BA; Diamond RH; Chen DM; Pritchard ML; Sandborn WJ
    Clin Gastroenterol Hepatol; 2006 May; 4(5):621-30. PubMed ID: 16678077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations.
    Lightner AL; McKenna NP; Tse CS; Raffals LE; Loftus EV; Mathis KL
    Aliment Pharmacol Ther; 2018 Mar; 47(5):573-580. PubMed ID: 29250800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining Predictors for Intra-abdominal Septic Complications Following Ileocolonic Resection for Crohn's Disease-Considerations in Pre-operative and Peri-operative Optimisation Techniques to Improve Outcome.
    Morar PS; Hodgkinson JD; Thalayasingam S; Koysombat K; Purcell M; Hart AL; Warusavitarne J; Faiz O
    J Crohns Colitis; 2015 Jun; 9(6):483-91. PubMed ID: 25796553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery.
    Kasparek MS; Bruckmeier A; Beigel F; Müller MH; Brand S; Mansmann U; Jauch KW; Ochsenkühn T; Kreis ME
    Inflamm Bowel Dis; 2012 Jul; 18(7):1207-13. PubMed ID: 21928373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy.
    Myrelid P; Marti-Gallostra M; Ashraf S; Sunde ML; Tholin M; Oresland T; Lovegrove RE; Tøttrup A; Kjaer DW; George BD
    Br J Surg; 2014 Apr; 101(5):539-45. PubMed ID: 24615529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image-guided Percutaneous Drainage for Treatment of Post-Surgical Anastomotic Leak in Patients with Crohn's Disease.
    Byrne J; Stephens R; Isaacson A; Yu H; Burke C
    J Crohns Colitis; 2016 Jan; 10(1):38-42. PubMed ID: 26417048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of post-operative complications in patients with Crohn's disease treated with anti-tumour necrosis factor α agents - a systematic review.
    El-Hussuna A; Theede K; Olaison G
    Dan Med J; 2014 Dec; 61(12):A4975. PubMed ID: 25441731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
    Billioud V; Ford AC; Tedesco ED; Colombel JF; Roblin X; Peyrin-Biroulet L
    J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally invasive colectomy for Crohn's colitis: a single institution experience.
    Holubar SD; Dozois EJ; Privitera A; Pemberton JH; Cima RR; Larson DW
    Inflamm Bowel Dis; 2010 Nov; 16(11):1940-6. PubMed ID: 20848480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review with meta-analysis: risk of post-operative complications associated with pre-operative exposure to anti-tumour necrosis factor agents for Crohn's disease.
    Lin YS; Cheng SW; Wang YH; Chen KH; Fang CJ; Chen C
    Aliment Pharmacol Ther; 2019 Apr; 49(8):966-977. PubMed ID: 30864199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis: The Influence of Preoperative Infliximab Use on Postoperative Complications of Crohn's Disease.
    Xu Y; Yang L; An P; Zhou B; Liu G
    Inflamm Bowel Dis; 2019 Jan; 25(2):261-269. PubMed ID: 30052982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bowel preparation for elective colectomy in Crohn's disease: results from a global cohort study using the NSQIP database.
    Callado GY; de Almeida Leite RM; Araujo SEA; Barchi LC; Seddiq W; Correa IP; Junior UR; Ricciardi R
    Colorectal Dis; 2024 Apr; 26(4):709-715. PubMed ID: 38385895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for surgical site infection and association with infliximab administration during surgery for Crohn's disease.
    Uchino M; Ikeuchi H; Matsuoka H; Bando T; Ichiki K; Nakajima K; Tomita N; Takesue Y
    Dis Colon Rectum; 2013 Oct; 56(10):1156-65. PubMed ID: 24022533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.